Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
This syndrome is characterized by the association of total alopecia (present at birth), mild intellectual deficit and hypergonadotropic hypogonadism.
Biomarker and diagnostic research for alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome.
104 publications have been identified in PubMed for alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome. Kisho has analyzed 82 by research type. Research spans Review / Meta-Analysis (70%), Basic Science / Preclinical (17%), and Epidemiology / Natural History (7%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 57 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 3:28 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research | 14 | 17% |
Disease patterns and progression | 6 | 7% |
Patient case studies | 3 | 4% |
Testing and diagnosis research | 2 | 2% |
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Hart SA (2026). [PMID: 41457053](https://pubmed.ncbi.nlm.nih.gov/41457053/). *Mol Genet Genomic Med*. [Epidemiology / Natural History]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Dotan A (2025). [PMID: 39931017](https://pubmed.ncbi.nlm.nih.gov/39931017/). *Harefuah*. [Review / Meta-Analysis]
Wang Y (2025). [PMID: 41137173](https://pubmed.ncbi.nlm.nih.gov/41137173/). *Genome Med*. [Epidemiology / Natural History]
Zhang Y (2025). [PMID: 40696433](https://pubmed.ncbi.nlm.nih.gov/40696433/). *Hum Genomics*. [Review / Meta-Analysis]
Sakuma H (2025). [PMID: 39143740](https://pubmed.ncbi.nlm.nih.gov/39143740/). *Dev Med Child Neurol*. [Review / Meta-Analysis]
Karuntu JS (2025). [PMID: 39733931](https://pubmed.ncbi.nlm.nih.gov/39733931/). *Prog Retin Eye Res*. [Review / Meta-Analysis]
Sahoo SS (2025). [PMID: 39475954](https://pubmed.ncbi.nlm.nih.gov/39475954/). *Blood*. [Review / Meta-Analysis]